Bounded outcome score modeling: application to treating psoriasis with ustekinumab

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.38, Iss.4, 2011-08, pp. : 497-517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure–response modeling of physician’s global assessment score for ustekinumab in patients with psoriasis

By Hu Chuanpu Szapary Philippe Yeilding Newman Zhou Honghui

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 2, 2011-04 ,pp. : 237-260

Springer Publishing Company

Access to resources Recommend Favorite

Ustekinumab proves positive for psoriasis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Ustekinumab a smooth operator in plaque psoriasis

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Long-term safety of ustekinumab for psoriasis

By Kumar Neal Narang Kirti Cressey Brienne D Gottlieb Alice B

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 757-765

Informa Healthcare

Access to resources Recommend Favorite

Ustekinumab: A New Option in Psoriasis Therapy

By Chien Anna L. Elder James T. Ellis Charles N.

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1141-1152

Adis International

Access to resources Recommend Favorite